HEADER TRANSFERASE/ANTIBIOTIC 02-MAY-12 4EZ7 TITLE CDK2 IN COMPLEX WITH STAUROSPORINE AND 2 MOLECULES OF 8-ANILINO-1- TITLE 2 NAPHTHALENE SULFONIC ACID COMPND MOL_ID: 1; COMPND 2 MOLECULE: CYCLIN-DEPENDENT KINASE 2; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: CDK2, CELL DIVISION PROTEIN KINASE 2, P33 PROTEIN KINASE; COMPND 5 EC: 2.7.11.22; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: CDK2, CDKN2; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: TUNER(DE3); SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PGEX6P-1 KEYWDS PROTEIN KINASE, ANS, TRANSFERASE-ANTIBIOTIC COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR R.ALAM,M.P.MARTIN,J.-Y.ZHU,E.SCHONBRUNN REVDAT 3 13-SEP-23 4EZ7 1 REMARK SEQADV REVDAT 2 03-OCT-12 4EZ7 1 JRNL REVDAT 1 22-AUG-12 4EZ7 0 JRNL AUTH M.P.MARTIN,R.ALAM,S.BETZI,D.J.INGLES,J.Y.ZHU,E.SCHONBRUNN JRNL TITL A NOVEL APPROACH TO THE DISCOVERY OF SMALL-MOLECULE LIGANDS JRNL TITL 2 OF CDK2. JRNL REF CHEMBIOCHEM V. 13 2128 2012 JRNL REFN ISSN 1439-4227 JRNL PMID 22893598 JRNL DOI 10.1002/CBIC.201200316 REMARK 2 REMARK 2 RESOLUTION. 2.49 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX (PHENIX.REFINE: 1.7.3_928) REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ENGH & HUBER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.49 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 19.77 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.340 REMARK 3 COMPLETENESS FOR RANGE (%) : 96.9 REMARK 3 NUMBER OF REFLECTIONS : 9544 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : NULL REMARK 3 R VALUE (WORKING SET) : 0.220 REMARK 3 FREE R VALUE : 0.274 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 3.880 REMARK 3 FREE R VALUE TEST SET COUNT : 370 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 19.7688 - 3.5867 1.00 3242 127 0.2026 0.2519 REMARK 3 2 3.5867 - 2.8496 0.98 3057 125 0.2180 0.2934 REMARK 3 3 2.8496 - 2.4900 0.93 2875 118 0.2748 0.3223 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.10 REMARK 3 SHRINKAGE RADIUS : 0.86 REMARK 3 K_SOL : 0.32 REMARK 3 B_SOL : 24.84 REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.290 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 27.070 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 8.04130 REMARK 3 B22 (A**2) : 22.69900 REMARK 3 B33 (A**2) : 2.95010 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.007 2595 REMARK 3 ANGLE : 1.087 3530 REMARK 3 CHIRALITY : 0.070 385 REMARK 3 PLANARITY : 0.005 435 REMARK 3 DIHEDRAL : 15.272 964 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 4EZ7 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 14-MAY-12. REMARK 100 THE DEPOSITION ID IS D_1000072253. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 15-APR-12 REMARK 200 TEMPERATURE (KELVIN) : 93 REMARK 200 PH : 7.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU MICROMAX-007 HF REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.54 REMARK 200 MONOCHROMATOR : MIRRORS REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : RIGAKU SATURN 944+ REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 9886 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.490 REMARK 200 RESOLUTION RANGE LOW (A) : 20.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 97.2 REMARK 200 DATA REDUNDANCY : 6.900 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : 0.06600 REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 47.4000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.49 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.54 REMARK 200 COMPLETENESS FOR SHELL (%) : 90.0 REMARK 200 DATA REDUNDANCY IN SHELL : 3.60 REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : 0.30400 REMARK 200 <I/SIGMA(I)> FOR SHELL : 6.700 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHENIX REMARK 200 STARTING MODEL: PDB ENTRY 3PXF REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 36.23 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 1.93 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 5 MG/ML CDK2 PROTEIN, 50 MM REMARK 280 SODIUM/POTASSIUM PHOSPHATE, PH 7.5, 50 MM HEPES, PH 7.5, 5% V/V REMARK 280 PEG3350, 1 MM STAUROSPORINE OVERNIGHT SOAK FOLLOWED BY 20 MM ANS REMARK 280 SOAK (50 MM HEPES, 50 MM PHOSPHATE, 15% V/V PEG3350, 25% V/V REMARK 280 GLYCEROL), VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 291K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 26.61950 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 35.89050 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 35.08750 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 35.89050 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 26.61950 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 35.08750 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A -7 REMARK 465 PRO A -6 REMARK 465 LEU A -5 REMARK 465 GLY A -4 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 THR A 39 77.67 -67.04 REMARK 500 GLU A 40 -66.97 -97.70 REMARK 500 GLU A 42 0.88 82.20 REMARK 500 SER A 46 -5.47 88.08 REMARK 500 ARG A 126 -15.90 71.45 REMARK 500 ASP A 127 47.26 -141.62 REMARK 500 ALA A 151 -125.19 59.73 REMARK 500 TYR A 159 39.90 76.75 REMARK 500 SER A 181 -169.98 -128.69 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE STU A 301 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 2AN A 302 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 2AN A 303 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO A 304 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO A 305 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO A 306 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO A 307 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 4ERW RELATED DB: PDB REMARK 900 RELATED ID: 4EZ3 RELATED DB: PDB DBREF 4EZ7 A 1 298 UNP P24941 CDK2_HUMAN 1 298 SEQADV 4EZ7 GLY A -7 UNP P24941 EXPRESSION TAG SEQADV 4EZ7 PRO A -6 UNP P24941 EXPRESSION TAG SEQADV 4EZ7 LEU A -5 UNP P24941 EXPRESSION TAG SEQADV 4EZ7 GLY A -4 UNP P24941 EXPRESSION TAG SEQADV 4EZ7 SER A -3 UNP P24941 EXPRESSION TAG SEQADV 4EZ7 PRO A -2 UNP P24941 EXPRESSION TAG SEQADV 4EZ7 GLU A -1 UNP P24941 EXPRESSION TAG SEQADV 4EZ7 PHE A 0 UNP P24941 EXPRESSION TAG SEQRES 1 A 306 GLY PRO LEU GLY SER PRO GLU PHE MET GLU ASN PHE GLN SEQRES 2 A 306 LYS VAL GLU LYS ILE GLY GLU GLY THR TYR GLY VAL VAL SEQRES 3 A 306 TYR LYS ALA ARG ASN LYS LEU THR GLY GLU VAL VAL ALA SEQRES 4 A 306 LEU LYS LYS ILE ARG LEU ASP THR GLU THR GLU GLY VAL SEQRES 5 A 306 PRO SER THR ALA ILE ARG GLU ILE SER LEU LEU LYS GLU SEQRES 6 A 306 LEU ASN HIS PRO ASN ILE VAL LYS LEU LEU ASP VAL ILE SEQRES 7 A 306 HIS THR GLU ASN LYS LEU TYR LEU VAL PHE GLU PHE LEU SEQRES 8 A 306 HIS GLN ASP LEU LYS LYS PHE MET ASP ALA SER ALA LEU SEQRES 9 A 306 THR GLY ILE PRO LEU PRO LEU ILE LYS SER TYR LEU PHE SEQRES 10 A 306 GLN LEU LEU GLN GLY LEU ALA PHE CYS HIS SER HIS ARG SEQRES 11 A 306 VAL LEU HIS ARG ASP LEU LYS PRO GLN ASN LEU LEU ILE SEQRES 12 A 306 ASN THR GLU GLY ALA ILE LYS LEU ALA ASP PHE GLY LEU SEQRES 13 A 306 ALA ARG ALA PHE GLY VAL PRO VAL ARG THR TYR THR HIS SEQRES 14 A 306 GLU VAL VAL THR LEU TRP TYR ARG ALA PRO GLU ILE LEU SEQRES 15 A 306 LEU GLY CYS LYS TYR TYR SER THR ALA VAL ASP ILE TRP SEQRES 16 A 306 SER LEU GLY CYS ILE PHE ALA GLU MET VAL THR ARG ARG SEQRES 17 A 306 ALA LEU PHE PRO GLY ASP SER GLU ILE ASP GLN LEU PHE SEQRES 18 A 306 ARG ILE PHE ARG THR LEU GLY THR PRO ASP GLU VAL VAL SEQRES 19 A 306 TRP PRO GLY VAL THR SER MET PRO ASP TYR LYS PRO SER SEQRES 20 A 306 PHE PRO LYS TRP ALA ARG GLN ASP PHE SER LYS VAL VAL SEQRES 21 A 306 PRO PRO LEU ASP GLU ASP GLY ARG SER LEU LEU SER GLN SEQRES 22 A 306 MET LEU HIS TYR ASP PRO ASN LYS ARG ILE SER ALA LYS SEQRES 23 A 306 ALA ALA LEU ALA HIS PRO PHE PHE GLN ASP VAL THR LYS SEQRES 24 A 306 PRO VAL PRO HIS LEU ARG LEU HET STU A 301 35 HET 2AN A 302 21 HET 2AN A 303 21 HET EDO A 304 4 HET EDO A 305 4 HET EDO A 306 4 HET EDO A 307 4 HETNAM STU STAUROSPORINE HETNAM 2AN 8-ANILINO-1-NAPHTHALENE SULFONATE HETNAM EDO 1,2-ETHANEDIOL HETSYN EDO ETHYLENE GLYCOL FORMUL 2 STU C28 H26 N4 O3 FORMUL 3 2AN 2(C16 H13 N O3 S) FORMUL 5 EDO 4(C2 H6 O2) FORMUL 9 HOH *40(H2 O) HELIX 1 1 PHE A 0 GLU A 2 5 3 HELIX 2 2 THR A 47 LEU A 58 1 12 HELIX 3 3 LEU A 87 SER A 94 1 8 HELIX 4 4 PRO A 100 SER A 120 1 21 HELIX 5 5 LYS A 129 GLN A 131 5 3 HELIX 6 6 VAL A 164 ARG A 169 5 6 HELIX 7 7 ALA A 170 LEU A 175 1 6 HELIX 8 8 THR A 182 ARG A 199 1 18 HELIX 9 9 SER A 207 GLY A 220 1 14 HELIX 10 10 GLY A 229 MET A 233 5 5 HELIX 11 11 ASP A 247 VAL A 252 1 6 HELIX 12 12 ASP A 256 LEU A 267 1 12 HELIX 13 13 SER A 276 LEU A 281 1 6 HELIX 14 14 ALA A 282 GLN A 287 5 6 SHEET 1 A 5 PHE A 4 GLU A 12 0 SHEET 2 A 5 VAL A 17 ASN A 23 -1 O LYS A 20 N GLU A 8 SHEET 3 A 5 VAL A 29 ILE A 35 -1 O VAL A 30 N ALA A 21 SHEET 4 A 5 LYS A 75 GLU A 81 -1 O PHE A 80 N ALA A 31 SHEET 5 A 5 LEU A 66 THR A 72 -1 N THR A 72 O LYS A 75 SHEET 1 B 3 GLN A 85 ASP A 86 0 SHEET 2 B 3 LEU A 133 ILE A 135 -1 O ILE A 135 N GLN A 85 SHEET 3 B 3 ILE A 141 LEU A 143 -1 O LYS A 142 N LEU A 134 CISPEP 1 PHE A 152 GLY A 153 0 5.51 SITE 1 AC1 16 ILE A 10 GLY A 11 GLU A 12 GLY A 13 SITE 2 AC1 16 VAL A 18 ALA A 31 LYS A 33 GLU A 81 SITE 3 AC1 16 PHE A 82 LEU A 83 HIS A 84 GLN A 131 SITE 4 AC1 16 ASN A 132 LEU A 134 ASP A 145 2AN A 302 SITE 1 AC2 11 LYS A 33 ILE A 35 LEU A 55 VAL A 64 SITE 2 AC2 11 PHE A 80 ALA A 144 ASP A 145 PHE A 146 SITE 3 AC2 11 LEU A 148 STU A 301 HOH A 437 SITE 1 AC3 8 ILE A 52 LYS A 56 VAL A 69 HIS A 71 SITE 2 AC3 8 LEU A 76 LEU A 78 ASN A 272 HOH A 411 SITE 1 AC4 6 ARG A 245 SER A 264 LEU A 267 HIS A 268 SITE 2 AC4 6 TYR A 269 HOH A 415 SITE 1 AC5 6 LEU A 58 ASN A 59 HIS A 60 ILE A 63 SITE 2 AC5 6 VAL A 64 LYS A 65 SITE 1 AC6 7 ARG A 126 ASP A 127 LEU A 128 THR A 165 SITE 2 AC6 7 TYR A 168 ARG A 169 HOH A 412 SITE 1 AC7 8 GLU A 28 VAL A 29 VAL A 30 GLU A 81 SITE 2 AC7 8 PHE A 82 ASP A 256 GLU A 257 ARG A 260 CRYST1 53.239 70.175 71.781 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.018783 0.000000 0.000000 0.00000 SCALE2 0.000000 0.014250 0.000000 0.00000 SCALE3 0.000000 0.000000 0.013931 0.00000